Stearic Acid Pharmaceutical USP/EP (Pharmacopeial Saturated C18 Fatty Acid Tablet Lubricant Cream Emulsifier) Storage

Stearic Acid Pharmaceutical USP/EP (Pharmacopeial-Grade Saturated C18 Fatty Acid; Stearic + Palmitic Acid Blend) Storage — Compendial Stearic Acid Tank Selection at Pharmaceutical Tablet-Manufacturing, Ointment-Base, and Cosmetic-Cream Operations

Stearic Acid Pharmaceutical USP (also called pharmaceutical stearic acid USP, octadecanoic acid + hexadecanoic acid blend; CAS 57-11-4 for stearic acid + 57-10-3 for palmitic acid; mixture of saturated long-chain fatty acids C16-C18; molecular weight ~280 g/mol average) is a white to faintly yellow, slightly glossy, waxy + crystalline solid existing as flakes, beads, granules, or powder, produced by hydrolysis + steam-distillation + fractional crystallization + hydrogenation of vegetable + animal triglyceride feedstocks (palm oil, palm kernel oil, coconut oil, tallow, soybean oil) followed by fractional separation of the C16 (palmitic) and C18 (stearic) saturated fatty acids. The USP-43-NF-38 Stearic Acid monograph and Ph. Eur. 11.0 Stearic Acid monograph specify three sub-grades by C18:C16 ratio: Stearic Acid 50 (stearic 40-50%, palmitic 50-60%), Stearic Acid 70 (stearic 60-80%, palmitic 20-40%), and Stearic Acid 95 (stearic above 90%, palmitic under 10%); melting range 54-69°C (varies by sub-grade); acid value 194-212; saponification value 195-211; iodine value under 4; loss on drying under 0.2%; residue on ignition under 0.1%; nickel under 1 ppm (residual hydrogenation catalyst); chloride under 0.07%; sulfate under 0.13%; arsenic under 1 ppm; heavy metals under 5 ppm.

Pharmaceutical USP stearic acid functions as tablet lubricant + capsule-shell lubricant + ointment-base hardener + suppository-base hardener + emulsifier (saponified to stearate soap in alkaline emulsion) + cream + lotion thickener across an extensive pharmaceutical and OTC + cosmetic formulation set. Tablet-press lubricant inclusion 1-3% w/w in solid-dose tablet manufacturing across virtually every immediate-release tablet product on the market (a critical excipient at every Big Pharma + generic tablet manufacturing operation: AbbVie, Pfizer, Merck, GSK, Sanofi, Teva, Sandoz, Apotex, Mylan, Sun Pharma, Aurobindo, Lupin, Cipla); tablet manufacturing volume of stearic acid is the largest pharmaceutical use volume globally. Cosmetic emulsifier inclusion 5-25% in oil-in-water cream + lotion bases (where it saponifies in-situ to stearate soap with KOH or TEA) at L'Oreal, Beiersdorf, Procter & Gamble Beauty, Unilever Personal Care. Suppository hardener at Catalent + Padagis. Soap bar manufacture at Dial (Henkel), Unilever, P&G. Physical properties: density 0.85 g/cm³; specific gravity 0.85; melting range 54-69°C (sub-grade dependent); flash point 196°C closed cup; autoignition 395°C; insoluble in water; soluble in hot ethanol, ether, chloroform, hot mineral oil; saponifies in alkaline aqueous + alcoholic solutions to soluble alkali stearate.

The eight sections below cite USP-NF 43, Ph. Eur. 11.0, JP 18, FDA 21 CFR Parts 210 + 211 + 600-680, USP <401> Fats and Fixed Oils, USP <731> Loss on Drying, USP <1116> Microbial Bioburden, ASME BPE-2022, ICH Q3D + Q3C + Q7 + Q9 + Q10, FDA 21 CFR 184.1090 GRAS Stearic Acid + 21 CFR 172.860 direct food-additive authorization, and operating practice at IOI Loders Croklaan, KLK OLEO USA, Wilmar International, Cargill (Cargill Bioindustrial), Croda, Emery Oleochemicals (PMC Group), AAK USA, Vantage Specialty Chemicals, and pharmaceutical manufacturing operations at major tablet-manufacturing + cosmetic + soap-manufacturing customers worldwide.

1. Material Compatibility Matrix

Pharmaceutical USP stearic acid is a chemically gentle saturated long-chain fatty acid with low acid-attack character at the solid + low-temperature melt-handled state, no oxidizer character, no halogen or sulfur species, and emulsifying capability via in-situ alkaline saponification. Material selection is driven by elevated-temperature melt-service (above 65-75°C process temperature) which limits HDPE applicability to short-term staging.

The dominant industrial pattern at pharmaceutical stearic-acid-using manufacturing is solid-form ambient bulk-receipt + steam-jacketed 316L stainless heated kettles for product-contact ointment + cream + emulsion preparation; HDPE rotomolded tanks at bulk-receipt + raw-material-warehouse staging where stearic acid is held as flakes / beads / granules in fiber drums + HDPE supersacks + bulk-bags at ambient. Stearic acid's solid form at room temperature makes liquid bulk-storage uncommon; the dominant supply form is solid bead / flake / pastilles at ambient with on-demand melting at the formulation kettle. OneSource Plastics' 5-brand HDPE network covers the bulk-receipt + raw-material-warehouse + compounding-pharmacy ambient-temperature solid-form staging; ASME BPE 316L sanitary stainless heated kettles for product-contact ointment + cream + tablet-lubricant blending are outside the HDPE scope.

2. Real-World Industrial Use Cases

Tablet Press Lubricant. USP stearic acid (typically Stearic Acid 50 or Stearic Acid 70 sub-grade) functions as the most widely used tablet-press lubricant + flow-aid in solid-dose pharmaceutical tablet manufacturing across virtually every immediate-release tablet product. Magnesium stearate (the calcium + magnesium salt of stearic acid; USP-NF Magnesium Stearate is the dominant tablet-lubricant API) is the iconic tablet-lubricant excipient; pure stearic acid USP at 1-3% w/w is used as alternative + supplement in formulations where calcium-stearate or magnesium-stearate physical properties are not optimal. Tablet manufacturing at AbbVie, Pfizer, Merck, GSK, Sanofi, Teva, Sandoz, Apotex, Mylan, Sun Pharma, Aurobindo, Lupin, Cipla, Wockhardt, Glenmark, Dr Reddy's, Cadila, and contract tablet manufacturers Catalent + Lonza + Hovione + Pfizer CentreOne.

Cosmetic Cream + Lotion Base. USP stearic acid (typically Stearic Acid 70 or Stearic Acid 95 sub-grade) functions as the principal saponification-emulsifier + thickener + opacifier in oil-in-water cosmetic cream + lotion bases. Inclusion 5-25% w/w; the stearic acid is saponified in-situ during the manufacturing process by KOH (potassium hydroxide) or TEA (triethanolamine) or AMP (aminomethylpropanol) to produce alkali-stearate soap which functions as the cream's primary emulsifier system. The classic vanishing-cream + cold-cream + face-cream + body-lotion technology is built around in-situ stearic-acid saponification. Manufacturing at L'Oreal, Beiersdorf, P&G Beauty, Unilever Personal Care, Estee Lauder, Coty, Shiseido, Amorepacific.

Suppository Base Hardener. USP stearic acid functions as hardness modifier + texturizer in suppository base formulations alongside cocoa butter, mineral oil, petrolatum, lanolin, and PEG bases; particularly used in pediatric + geriatric rectal-suppository formulations where melt-temperature design + structural-integrity-at-room-temperature is important. Inclusion 2-10% w/w in suppository base. Manufacturing at Ferring Pharmaceuticals, Catalent, Padagis, Perrigo.

Soft-Gel Capsule Shell + Plasticizer. USP stearic acid (and magnesium stearate) is used as soft-gel capsule shell-mold lubricant + capsule-fill flow-aid in soft-gelatin capsule manufacturing across vitamins, dietary supplements, and prescription pharmaceuticals. Soft-gel manufacturing at Catalent (largest global soft-gel manufacturer), Patheon, IFE Pharma, Sirio Pharma, Aenova.

Soap Bar + Detergent Manufacturing. USP-grade and food-grade stearic acid is included in toilet-soap + bath-bar + facial-soap + medicated-soap formulations as primary fatty-acid component (saponified during the saponification kettle reaction to soap bar). Inclusion typically 30-70% of the fatty-acid blend in milled-soap manufacturing. Manufacturing at Dial (Henkel), Unilever Lever Brothers + Dove + Lifebuoy, Procter & Gamble Ivory + Camay + Zest, J&J Body Care, Colgate-Palmolive Soap.

Lipstick + Lip-Balm Hardener. USP stearic acid functions as melt-temperature modifier + hardness modifier + pearling agent in lipstick + lip-balm + lip-care cosmetic formulations. Inclusion 5-30% w/w. Manufacturing at major cosmetic + personal-care manufacturers worldwide.

Compounding Pharmacy Working Stocks. 503A + 503B compounding operations stock USP stearic acid in 1-pound to 5-pound to 30-pound HDPE pails + fiber drums for use in patient-specific topical, suppository, and tablet-compounded preparations under USP <795> non-sterile compounding standards.

3. Regulatory Hazard Communication

OSHA HazCom GHS Classification. USP pharmaceutical stearic acid is not classified as a GHS hazardous substance. Flash point 196°C; not flammable in normal handling; melted stearic acid at heated-kettle service (75-95°C process) is well below flash. No GHS health-hazard classifications at oral, dermal, or inhalation routes (extensive feeding-study + dermal + inhalation safety testing places stearic acid at GRAS for food + cosmetic + pharmaceutical use per FDA 21 CFR 184.1090 + 172.860). Dust-inhalation potential at solid-handling operations triggers nuisance-dust + respiratory irritation classification at PEL above 15 mg/m³ total dust (OSHA general-industry threshold). Environmental: rapidly biodegradable; fish LC₅₀ over 100 mg/L. H-statements: typically none required. P-statements: P210 Keep away from open flames + hot surfaces (heated melt above flash); P261 Avoid breathing dust at solid-handling; P403+P233 Store in well-ventilated area.

FDA cGMP Compliance Framework. Pharmaceutical USP stearic acid used in finished drug products is regulated under 21 CFR Part 210 + 211 (finished pharmaceuticals) and 21 CFR Parts 600-680 (biologics). Identity testing per 21 CFR 211.84(d)(2) requires at least one specific identity test on each container received; USP identification by IR spectrum + acid value + saponification value + iodine value + melting range + sub-grade composition (gas chromatography) are the standard pharmacopeial identity panel. ICH Q3D + Q3C apply to elemental + residual-solvent impurities. ICH Q5A viral safety considerations apply when stearic acid is sourced from animal-derived feedstock (tallow); plant-derived stearic acid (palm + soybean + coconut origin) is increasingly preferred at pharmaceutical operations to avoid TSE/BSE concerns + accommodate vegan / vegetarian + halal + kosher requirements.

USP-NF 43 Compendial Specifications. Pharmacopeial harmonized stearic acid specifications: identification by IR spectrum + acid value 194-212 + saponification value 195-211 + iodine value under 4 + melting range (54-65°C for Stearic Acid 50; 60-69°C for Stearic Acid 70 + 95); sub-grade composition by gas chromatography of fatty-acid methyl esters (FAME); loss on drying under 0.2%; chloride under 0.07%; sulfate under 0.13%; nickel under 1 ppm (residual hydrogenation catalyst); arsenic under 1 ppm; heavy metals under 5 ppm; ICH Q3D elemental impurities; ICH Q3C residual solvents.

DOT and Shipping. USP stearic acid is not regulated under 49 CFR DOT Hazardous Materials Regulations. No UN number, no hazard class, no packing group. Shipped as standard non-hazardous solid in fiber drums (50-300-lb), HDPE supersacks + bulk-bags (1000-2200-lb), HDPE pails (5-30-lb), or solid-form tank-truck (heated tanker for molten bulk delivery; less common at pharmaceutical operations than at industrial soap-manufacturing customers).

EPA Air Regulations. Stearic acid storage tanks (heated bulk service) not subject to 40 CFR Part 60 NSPS Subpart Kb (vapor pressure under 0.001 psi at 90°C); not subject to Subpart K, KKK, or similar air regulations. Pharmaceutical manufacturing facilities subject to 40 CFR Part 63 Subpart GGG NESHAP for organic HAPs; stearic acid is not a HAP.

FDA Food + Cosmetic Authorization. Stearic acid holds GRAS status per FDA 21 CFR 184.1090 (direct human food additive affirmed GRAS) + 172.860 (food additive permitted in food for human consumption); cosmetic-ingredient status per FDA cosmetic regulations + CIR (Cosmetic Ingredient Review) safety panel review; EU food-additive authorization E570 and cosmetic-ingredient authorization under Cosmetics Regulation (EC) 1223/2009.

4. Storage System Specification

Bulk-Receipt and Raw-Material-Warehouse Storage. Pharmaceutical USP stearic acid arrives at the manufacturing facility raw-material warehouse via 1-pound to 5-pound to 30-pound HDPE pails + 50-300-lb fiber drums + 1000-2200-lb HDPE supersacks (the dominant package form at pharmaceutical operations) at solid bead / flake / pastilles ambient form. Bulk molten-tanker delivery (heated tanker) is uncommon at pharmaceutical operations but standard at large soap-manufacturing customers. Bulk-receipt storage at the warehouse uses ambient HDPE shelving + drum-stage areas + supersack-stage racks; on-demand melting at the formulation kettle is the standard production sequence.

Tank Sizing and Heating. Stearic acid is rarely held in long-term liquid bulk-storage at pharmaceutical operations; the dominant pattern is solid-form staging at the warehouse + on-demand drum-melting or supersack-discharge-to-melter at the production day. Mid-size and large operations may maintain 200-2000 gallon heated insulated kettle reservoirs of melted stearic acid during production campaigns; these are 316L stainless rather than HDPE due to extended elevated-temperature service (above 65-75°C). Soap-manufacturing operations operate at much larger heated-kettle scale (10,000-50,000 gallon saponification kettles) with carbon-steel or 316L stainless construction.

Compounding Pharmacy Working-Stock Storage. Compounding pharmacies + 503A + 503B operations stock USP stearic acid in 1-pound to 5-pound to 30-pound HDPE pails at the ingredient warehouse + non-sterile + sterile compounding cleanroom. On-demand small-batch melting in stainless-steel kettles or hot-plate-melt at compounding bench. Working-stock turnover is typically 6-12 months for the sealed pail.

Product-Contact Formulation Tanks. Active formulation + compounding for finished tablet-lubricant-blend / ointment-base / cream-base / suppository-base / lipstick-base preparations occurs in steam-jacketed 316L electropolished sanitary stainless kettles per ASME BPE-2022 with internal surface finish Ra under 0.5 microns, all-welded 316L sanitary tri-clamp transfer piping, BPE diaphragm or ball valves, jacketed steam or hot-water temperature control (75-95°C process), top-mounted impeller agitation (anchor + scraped-surface preferred for high-viscosity ointment-base preparation), CIP/SIP capability via hot-water + saponifier cleaning cycles + steam-in-place sanitization.

Secondary Containment. Bulk-receipt stearic-acid storage at pharmaceutical operations is typically solid-form ambient, eliminating the primary spill-containment concern that applies to liquid storage. Heated-melt-kettle reservoirs are placed inside containment dishes + spill-control plans per facility-wide containment best-practice. Soap-manufacturing operations with bulk molten heated-tanker receipt include heated-tanker offload area + secondary-containment dikes per local fire-code + facility-engineering standards.

Dust Control at Solid-Handling. Stearic acid solid bead / flake / pastilles handling at supersack-discharge + drum-charging + kettle-charging stations creates moderate dust-loading potential; dust-collection ventilation + N95 dust-mask + proper engineering controls per OSHA 29 CFR 1910 + 29 CFR 1910.1000 PEL compliance. Stearic acid is a nuisance dust; not a hazardous-dust + not a combustible-dust at the bead / flake / pastille handling form (powder-form fines could carry combustible-dust hazard requiring NFPA 652 + 654 evaluation; bead + flake + pastille forms are below combustible-dust threshold).

5. Field Handling Reality

Operator PPE. Pharmaceutical operators handling USP stearic acid require standard pharmaceutical manufacturing PPE: cleanroom-grade gowning at sterile + cleanroom operations, safety glasses + lab coat + closed-toe shoes at non-cleanroom ingredient warehouse + bulk-receipt operations, nitrile gloves at all liquid-handling operations to prevent product cross-contamination; thermal gloves (Kevlar or insulated nitrile) at heated-melt drum-warming + kettle-charging operations; N95 dust mask at solid-bead-handling + supersack-discharge stations. Spill-response gear at the bulk-receipt area. No respirator beyond N95 dust mask required at solid-handling; no respirator required at heated-melt service. Burn-first-aid station + emergency eyewash + safety-shower per OSHA 29 CFR 1910.151 first-aid requirements at heated-melt operations.

Microbial Bioburden Control + Oxidative Stability. Stearic acid's water-immiscibility + low free-water content + solid form + saturated fatty-acid composition makes bacterial + mold growth essentially zero in concentrated stearic acid at sealed-package storage; the principal stability concern is oxidative rancidity at any unsaturated impurity carryover (stearic acid 95 with under 4 iodine value is essentially stable for years; lower-grade stearic acid 50 with higher unsaturated content has shorter shelf life). Bulk-storage best practice includes sealed-pail + sealed-supersack storage, peroxide-value monitoring at the formulation lot, scheduled inspection for color-change + odor-change at pail + supersack opening, and validated lot-release retest of stored material if storage exceeds the manufacturer-stated shelf-life (typically 24-36 months for USP-grade sealed package).

Spill Response. Stearic acid spill response is a wax-cleanup operation: (1) allow spilled stearic acid to cool + solidify if heated-melt spill (solid-form stearic acid is straightforward to mechanical-collect via shovel + scraper + dustpan), (2) deploy mechanical scraper + putty-knife collection for solid material; oil-only sorbent pads for any residual liquid film, (3) collect into double-bagged poly waste for fatty-acid + pharmaceutical-waste profiling and disposal under facility-specific waste streams (typically non-RCRA, non-hazardous, profiled for incineration), (4) decontaminate spill area with degreaser + hot-water + detergent (stearic acid's water-immiscibility + lipid character makes degreaser-based hot-water cleaning the appropriate decontamination route; the wax-residue requires multiple cleaning passes for full removal), (5) document spill volume + decontamination + containment integrity for the facility deviation + investigation system per 21 CFR 211.192.

Slip Hazard. Liquid-melted stearic acid spill creates a slip hazard at heated-melt kettle + drum-warming station areas; solidified stearic acid residue creates a sticky-residue + slip hazard at floor + equipment surfaces. Slip-resistant floor mats + secondary containment at heated-melt operations + immediate spill response are essential.

Thermal Burn Hazard. Heated-melt stearic acid at 75-95°C process temperature presents a moderate-to-significant thermal-burn hazard at drum-warming station + kettle-charging + transfer-line operations; thermal-insulation gloves + face-shield + long-sleeve coverage + secondary-pan splash containment are standard PPE at heated-melt operations. Burn-first-aid station + emergency eyewash + safety-shower per OSHA 29 CFR 1910.151 first-aid + 29 CFR 1910 Appendix D.

Decontamination of Cross-Contamination Spills. Pharmaceutical manufacturing under 21 CFR 211.42 + 21 CFR 211.46 + 21 CFR 211.67 cleaning + cross-contamination prevention requires documented cleaning of any spill area + adjacent equipment + drains + transfer-piping returning to compendial-clean status. Stearic acid's water-immiscibility, persistence, and waxy-residue character make spill-area decontamination demanding; multi-pass hot-water + saponifier cleaning + degreaser wipe + residual-test-swab verification is the standard cross-contamination clearance protocol.

Talk to OneSource Plastics

Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.